OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on March 18, 2011. The report discloses the completion of an underwritten public offering of common stock, including the exercise of an over-allotment option by underwriters.
Key Financial Metrics
- Shares Issued (Over-Allotment): 2,397,029 shares of common stock.
- Offering Price: $3.75 per share.
- Net Proceeds: Approximately $8.5 million (after underwriting fees).
- Total Offering Context: This over-allotment was in connection with a previously announced offering of 27,000,000 shares.
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics beyond the proceeds from this specific transaction.
Material Changes
The primary material change is the increase in outstanding common stock and the infusion of capital resulting from the over-allotment exercise. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the press release information is not deemed "filed" under Section 18 of the Exchange Act. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the total number of shares outstanding post-offering (27,000,000 base + 2,397,029 over-allotment).
- Confirm the use of the approximately $8.5 million in net proceeds as described in the full press release (Exhibit 99.1).
- Review the underwriting agreement terms to understand any remaining obligations or lock-up periods.